Showing results (11-20 of 5,182) with videos related to

Sort By:
Pageof 519
Radiologic Clinics of North America|October 19, 2004
Investigation of thyroid, head, and neck cancers with PETHongming Zhuang, Rakesh Kumar, Susan Mandel, et al.
PET Clinics|June 18, 2022
18F-FDG Versus Non-FDG PET Tracers in Multiple MyelomaAngel Hemrom, Avinash Tupalli, Abass Alavi, et al.
PET Clinics|May 10, 2016
Normal Variants and Effects of Aging on the Gastrointestinal TractRakesh Kumar, Jaseena Elikkottil, Suhas Singla, et al.
PET Clinics|May 10, 2016
Exploring Tumor Biology with Fluorodeoxyglucose-Positron Emission Tomography Imaging in Breast CarcinomaSandip Basu, Rakesh Kumar, Ayşe Mavi, et al.
PET Clinics|June 18, 2022
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing MisconceptionsNadia Withofs, Rakesh Kumar, Abass Alavi, et al.
Radiologic Clinics of North America|February 8, 2005
Fluorodeoxyglucose-PET in the management of malignant melanomaRakesh Kumar, Ayse Mavi, Gonca Bural, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2007
Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodulesKhaled Alkhawaldeh, Gonca Bural, Rakesh Kumar, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|January 16, 2015
Use of 99m-technetium-glucoheptonate as a tracer for brain tumor imaging: An overview of its strengths and pitfallsAmburanjan Santra, Rakesh Kumar, Punit Sharma
PET Clinics|August 1, 2026
Esophageal and Gastric CancersAnushna Sunila Babu, Mohammad Umar, Abass Alavi, et al.
Radiologic Clinics of North America|October 19, 2004
Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomasRakesh Kumar, Ivan Maillard, Stephen J Schuster, et al.
Pageof 519